EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death. The accumulation of genetic and epigenetic changes is closely related to the occurrence and development of HCC. Enhancer of zeste homolog 2 (EZH2, a histone methyltransferase) is suggested to be one of the principal factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bohan, Liu, Yachong, Liao, Zhibin, Wu, Haofeng, Zhang, Bixiang, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236851/
https://www.ncbi.nlm.nih.gov/pubmed/37268997
http://dx.doi.org/10.1186/s40164-023-00405-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236851/
https://www.ncbi.nlm.nih.gov/pubmed/37268997
http://dx.doi.org/10.1186/s40164-023-00405-2

Ejemplares similares